MAFB Gene: V-Maf Avian Musculoaponeurotic Fibrosarcoma Oncogene Homolog B

A key transcription factor in hematopoietic differentiation and pancreatic development, implicated in multicentric carpotarsal osteolysis syndrome and multiple myeloma.

Gene Information Card

Symbol MAFB
Full Name MAF bZIP transcription factor B
Gene Type protein-coding
Chromosomal Location 20q12
NCBI Gene ID 9935 ncbi.nlm.nih.gov/gene/9935
Ensembl ID ENSG00000100225
UniProt ID Q9Y5Q3
OMIM ID 608968
HGNC ID 6777
Aliases KRML, MGC43127, bZIP transcription factor B

Description

MAFB (MAF bZIP transcription factor B) encodes a basic leucine zipper (bZIP) transcription factor that belongs to the MAF family. It plays critical roles in the regulation of hematopoiesis, particularly in monocyte/macrophage differentiation, and in pancreatic islet cell development. Mutations in MAFB are associated with multicentric carpotarsal osteolysis syndrome (MCTO) and have been implicated in multiple myeloma through chromosomal translocations and overexpression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Multicentric carpotarsal osteolysis syndrome (MCTO) Loss-of-function mutations in MAFB disrupt normal osteoclast and bone development, leading to progressive bone loss and carpotarsal osteolysis. ClinVar, OMIM
Multiple myeloma Chromosomal translocations (e.g., t(14;20)(q32;q12)) involving MAFB lead to its overexpression, contributing to plasma cell malignancy. COSMIC, NCBI, OMIM
Diabetes mellitus (type 2) MAFB is essential for pancreatic beta-cell development and function; variants may alter insulin secretion. OMIM, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 12.5 Medium
Pancreas 8.2 Medium
Bone marrow 6.8 Low
Spleen 5.1 Low
Lung 3.4 Low
Cell Line Expression
Cell Line nTPM Notes
K-562 (leukemia) 15.3 High expression
HEK 293 (embryonic kidney) 9.7 Medium expression
HeLa (cervical carcinoma) 4.2 Low expression
MCF7 (breast cancer) 2.1 Very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.266C>T (p.Ser89Leu) Missense Rare Loss of DNA-binding activity; associated with MCTO
c.437G>A (p.Arg146Gln) Missense Rare Impaired transcriptional activation; MCTO
t(14;20)(q32;q12) Translocation Somatic in multiple myeloma Overexpression of MAFB driven by IGH enhancer
c.1A>G (p.Met1Val) Start loss Rare Complete loss of protein; MCTO
Mutation functional classification

Loss of Function (LOF)

Missense and start-loss mutations in MAFB (e.g., p.Ser89Leu, p.Met1Val) result in loss of DNA binding or protein production, leading to haploinsufficiency and MCTO.

Gain of Function (GOF)

Chromosomal translocations (e.g., t(14;20)) cause MAFB overexpression in multiple myeloma, acting as an oncogenic driver.

Dominant Negative (DN)

Some missense variants may produce a protein that interferes with wild-type MAFB function, though dominant-negative effects are not well-documented for MAFB.

Pathways

• Hematopoietic cell lineage (KEGG:04640)
• Transcriptional misregulation in cancer (KEGG:05202)
• Signaling pathways regulating pluripotency of stem cells (KEGG:04550)

Protein Summary

MAFB is a 323-amino acid bZIP transcription factor that forms homodimers or heterodimers with other MAF family members. It binds to MAF recognition elements (MARE) in target gene promoters to regulate transcription. The protein contains an N-terminal transactivation domain and a C-terminal bZIP domain. MAFB is essential for monocyte/macrophage differentiation, osteoclast development, and pancreatic beta-cell maturation. Its dysregulation contributes to skeletal disorders and hematologic malignancies.

Related Products

Product name Cat.No. Species Gene ID
MAFB Knockout HEK293 Cell Line EDJ-KQ3355 Human 9935 Details Get a Quote
MAFB Knockout HeLa Cell Line EDJ-KQ25012 Human 9935 Details Get a Quote
MAFB Knockout A-549 Cell Line EDJ-KQ63761 Human 9935 Details Get a Quote
MAFB Knockout HCT 116 Cell Line EDJ-KQ72220 Human 9935 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: